NDC 55111-625

Zafirlukast

Zafirlukast

Zafirlukast is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddys Laboratories Limited. The primary component is Zafirlukast.

Product ID55111-625_b5fb9efb-3369-e1f9-384c-bd22e8ecad92
NDC55111-625
Product TypeHuman Prescription Drug
Proprietary NameZafirlukast
Generic NameZafirlukast
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2010-11-18
Marketing CategoryANDA / ANDA
Application NumberANDA090372
Labeler NameDr. Reddys Laboratories Limited
Substance NameZAFIRLUKAST
Active Ingredient Strength10 mg/1
Pharm ClassesLeukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Leukotriene Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 55111-625-01

100 TABLET, FILM COATED in 1 BOTTLE (55111-625-01)
Marketing Start Date2010-11-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55111-625-60 [55111062560]

Zafirlukast TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090372
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-11-18

NDC 55111-625-01 [55111062501]

Zafirlukast TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090372
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-18

NDC 55111-625-05 [55111062505]

Zafirlukast TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090372
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-18

NDC 55111-625-30 [55111062530]

Zafirlukast TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090372
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-18

NDC 55111-625-79 [55111062579]

Zafirlukast TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090372
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-18

NDC 55111-625-78 [55111062578]

Zafirlukast TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090372
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-18

Drug Details

Active Ingredients

IngredientStrength
ZAFIRLUKAST10 mg/1

OpenFDA Data

SPL SET ID:6ccb96af-2647-9206-5eee-49a825d32488
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313758
  • 199655
  • UPC Code
  • 0355111625605
  • 0355111626602
  • Pharmacological Class

    • Leukotriene Receptor Antagonists [MoA]
    • Cytochrome P450 2C9 Inhibitors [MoA]
    • Leukotriene Receptor Antagonist [EPC]
    • Leukotriene Receptor Antagonists [MoA]
    • Cytochrome P450 2C9 Inhibitors [MoA]
    • Leukotriene Receptor Antagonist [EPC]

    Medicade Reported Pricing

    55111062560 ZAFIRLUKAST 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Zafirlukast" or generic name "Zafirlukast"

    NDCBrand NameGeneric Name
    0904-6646Zafirlukastzafirlukast
    16571-654ZafirlukastZafirlukast
    16571-655ZafirlukastZafirlukast Tablets
    31722-007ZafirlukastZafirlukast
    31722-008ZafirlukastZafirlukast
    49884-549Zafirlukastzafirlukast
    49884-554Zafirlukastzafirlukast
    50268-805ZafirlukastZafirlukast
    55111-625ZafirlukastZafirlukast
    55111-626ZafirlukastZafirlukast
    63629-2102Zafirlukastzafirlukast
    64380-187Zafirlukastzafirlukast
    64380-188Zafirlukastzafirlukast
    68084-059ZafirlukastZafirlukast
    68151-1977ZafirlukastZafirlukast
    49884-010ACCOLATEzafirlukast
    49884-011ACCOLATEzafirlukast
    49884-589Accolatezafirlukast
    49884-590Accolatezafirlukast
    53808-0203ACCOLATEZafirlukast
    64380-177ACCOLATEZafirlukast
    64380-178ACCOLATEZafirlukast

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.